p53 mutation analysis in breast tumors by a DNA microarray method

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 1, 2006, Pages 80-85

  Tennis, Meredith ^a   Krishnan, Shiva ^a   Bonner, Matthew ^b   Ambrosone, Christine B ^b   Vena, John E ^c   Moysich, Kirsten ^b   Swede, Helen ^b   McCann, Susan ^b   Hall, Per ^d   Shields, Peter G ^a   Freudenheim, Jo L ^b  

^a GEORGETOWN UNIVERSITY   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; DNA; PARAFFIN;

ANALYTIC METHOD; ARTICLE; BREAST CANCER; CELL GROWTH; CODON; DIAGNOSTIC VALUE; DNA EXTRACTION; DNA MICROARRAY; DNA REPAIR; EXON; FEMALE; GENE AMPLIFICATION; GENE FUNCTION; GENE IDENTIFICATION; GENE INACTIVATION; GENE MUTATION; HUMAN; LUNG TUMOR; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREDICTIVE VALIDITY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE; BREAST TUMOR; CASE CONTROL STUDY; COMPARATIVE STUDY; GENETICS; METHODOLOGY; MUTATION; NUCLEOTIDE SEQUENCE;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CODON; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; EXONS; FEMALE; GENES, P53; HUMANS; LUNG NEOPLASMS; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARAFFIN EMBEDDING; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33645456863     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0444     Document Type: Article

References (25)

1. Powell B, Soong R, Iacopetta B, et al. Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer. Clin Cancer Res 2000;6:443-51.
2. Borresen AL, Andersen TI, Eyfjord JE, et al. TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains. Genes Chromosomes Cancer 1995;14:71-5.
3. Dale LC, Ebbert JO, Schroeder DR, et al. Bupropion for the treatment of nicotine dependence in spit tobacco users: a pilot study. Nicotine Tob Res 2002;4:267-74.
4. Hartmann A, Blaszyk H, Kovach JS, et al. The molecular epidemiology of p53 gene mutations in human breast cancer. Trends Genet 1997;13:27-33.
5. Greenblatt MS, Bennett WP, Hollstein M, et al. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54:4855-78.
6. Brash DE, Rudolph JA, Simon JA, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A 1991;88:10124-8.
7. Ziegler A, Jonason AS, Leffell DJ, et al. Sunburn and p53 in the onset of skin cancer. Nature 1994;372:773-6.
8. Nakazawa H, English D, Randell PL, et al. UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. Proc Natl Acad Sci U S A 1994;91:360-4.
9. Hsu IC, Metcalf RA, Sun T, et al. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991;350:427-8.
10. Bressac B, Kew M, Wands J, et al. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991;350:429-31.
11. Brennan JA, Boyle JO, Koch WM, et al. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 1995;332:712-7.
12. Saitoh S, Cunningham J, De Vries EM, et al. p53 gene mutations in breast cancers in midwestern US women: null as well as missense-type mutations are associated with poor prognosis. Oncogene 1994;9:2869-75.
13. Marutani M, Tonoki H, Tada M, et al. Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastoma multiforme. Cancer Res 1999;59:4765-9.
14. Wen W, Bernstein L, Lescallett J, et al. Comparison of TP53 mutations identified by oligonucleotide microarray and conventional DNA sequence analysis. Cancer Res 2000;60:2716-22.
15. Ahrendt SA, Halachmi S, Chow JT, et al. Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array. Proc Natl Acad Sci U S A 1999;96:7382-7.
16. Cooper M, Li SQ, Bhardwaj T, et al. Evaluation of oligonucleotide arrays for sequencing of the p53 gene in DNA from formalin-fixed, paraffin-embedded breast cancer specimens. Clin Chem 2004;50:500-8.
17. Wikman FP, Lu ML, Thykjaer T, et al. Evaluation of the performance of a p53 sequencing microarray chip using 140 previously sequenced bladder tumor samples. Clin Chem 2000;46:1555-61.
18. Graham S, Hellmann R, Marshall J, et al. Nutritional epidemiology of postmenopausal breast cancer in western New York [see comments]. Am J Epidemiol 1991;134:552-66.
19. Freudenheim JL, Marshall JR, Vena JE, et al. Premenopausal breast cancer risk and intake of vegetables, fruits, and related nutrients. J Natl Cancer Inst 1996;88:340-8.
20. Ambrosone CB, Freudenheim JL, Sinha R, et al. Breast cancer risk, meat consumption and N-acetyltransferase (NAT2) genetic polymorphisms. Int J Cancer 1998;75:825-30.
21. Sepp R, Szabo I, Uda H, et al. Rapid techniques for DNA extraction from routinely processed archival tissue for use in PCR. J Clin Pathol 1994;47:318-23.
22. Vahakangas KH, Bennett WP, Castren K, et al. p53 and K-ras mutations in lung cancers from former and never-smoking women. Cancer Res 2001; 61:4350-6.
23. Powell B, Soong R, Iacopetta B, et al. Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer. Clin Cancer Res 2000;6:443-51.
24. Conway K, Edmiston SN, Cui L, et al. Prevalence and spectrum of p53 mutations associated with smoking in breast cancer. Cancer Res 2002; 62:1987-95.
25. Chen FM, Hou MF, Wang JY, et al. High frequency of G/C transversion on p53 gene alterations in breast cancers from Taiwan. Cancer Lett 2004;207:59-67.